Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain

Mayo Clinic Proceedings

Volumn 76, Issue 7, 2001, Pages 677-687

  Meyer, F B ^a   Bates, Lisa M ^a   Goerss, Stephan J ^a   Friedman, Jonathan A ^a   Windschitl, Wanda L ^a   Duffy, Joseph R ^a   Perkins, William J ^a   O’Neill, Brian P ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN REGION; CANCER GRADING; CANCER GROWTH; CANCER SURGERY; COMPUTER ASSISTED THERAPY; CRANIOTOMY; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATIENT MONITORING; SPEECH; STEREOTAXIC SURGERY; TUMOR VOLUME; WAKEFULNESS;

EID: 0034954818     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.7.677     Document Type: Article

References (71)

1. Lacoangeli M, Roselli R, Prezioso A, Scerrati M, Rossi GF. Staging of supratentorial hemispheric glioma using tumour extension, histopathological grade and extent of surgical resection. Er J Surg. 1993;80:1130-1133.
2. Laurent JP, Chang CH, Cohen ME. A classification system for primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. Cancer, 1985;56(7, suppl): 1807-1809.
3. Levin VA, Gutin PH, Leibel S. Neoplasms of the central nervous system. In: De Vita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 4th ed. Philadelphia, Pa: JB Lippincott Co; 1993:1679-1737.
4. Rosenblum ML. General surgical principles, alternatives, and limitations. Neurosurg Clin N Am, 1990;!: 19-36.
5. Ammirati M, Vick N, Liao YL, Ciric I, Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery. 1987 ;21:201-206.
6. Celli P, Nofrone I, Palma L, Cantore G, Fortuna A. Cerebral oligodendroglioma: prognostic factors and life history. Neurosurgery. 1994;35:1018-1034.
7. Ciric I, Ammirati M, Vick N, Mikhael M. Supratentorial gliomas: surgical considerations and immediate postoperative results: gross total resection versus partial resection. Neurosurgery. 1987;21:2126.
8. Forsting M, Albert FK, Kunze S, Adams HP, Zenner D, Sartor K. Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns. AJNRAm JNeuroradiol. 1993;14:7787.
9. Haglund MM, Berger MS, Shamseldin M, Lettich E, Ojemann GA. Cortical localization of temporal lobe language sites in patients with gliomas. Neurosurgery. 1994;34:567-576.
10. Hollerhage HG, Zumkeller M, Becker M, Dietz H. Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme. Acta Neurochir (Wien). 1991 ;113:31-37.
11. Janny P, Cure H, Mohr M, et al. Low grade supratentorial astrocytomas: management and prognostic factors. Cancer. 1994;73:19371945.
12. Jelsma R, Bucy PC. The treatment of glioblastoma multiforme of the brain. J Neurosurg. 1967;27:388-400.
13. Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neurooncol. 1994;21:177-185.
14. Kiwit JC, Floeth FW, Bock WJ. Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. Zentralbl Neurochir. 1996;57:76-88.
15. McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, Ransohoff J. Treatment and survival of low-grade astrocytoma in adults-1977-1988. Neurosurgery. 1992;31:636-642.
16. Nazzaro JM, Neuwelt EA. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg. 1990;73:331-344.
17. Nicolato A, Gerosa MA, Fina P, luzzolino P, Giorgiutti F, Bricolo A. Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients. Surg Neural 1995;44:208-221.
18. Nitta T, Sato K. Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer. 1995 ;75:2727-2731.
19. North CA, North RB, Epstein JA, Piantadosi S, Wharam MD. Lowgrade cerebral astrocytomas: survival and quality of life after radiation therapy. Cancer. 1990;66:6-14.
20. Piepmeier J, Christopher S, Spencer D, et al. Variations in the natural history and survival of patients with supratentorial lowgrade astrocytomas. Neurosurgery. 1996;38:872-878.
21. Pierallini A, Bonamini M, Osti MF, et al. Supratentorial glioblastoma: neuroradiological findings and survival after surgery and radiotherapy. Neuroradiology. 1996;38(suppl 1):S26-S30.
22. Quigley MR, Maroon JC. The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery. 1991;29:385-388.
23. Salcman M. Supratentorial gliomas: clinical features and surgical therapy. In: Wilkins RH, Rengachary SS, eds. Neurosurgery. Vol 1. 2nd ed. New York, NY: McGraw-Hill; 1996:777-788.
24. Sandeman DR, Sandeman AP, Buxton P, et al. The management of patients with an intrinsic supratentorial brain tumour. Br J Neurosurg. 1990;4:299-312.
25. Scerrati M, Roselli R, lacoangeli M, Pompucci A, Rossi GF. Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. / Neural Neurosurg Psychiatry. 1996;61:291-296.
26. Shaw EG, Scheithauer BW, O'Fallon JR. Management of supratentorial low grade gliomas. Oncology (Huntingt). 1993;7:97-104.
27. Shaw EG, Scheithauer BW, O'Fallon JR, Davis DH. Mixed oligoastrocytomas: a survival and prognostic factor analysis. Neurosurgery. 1994;34:577-582.
28. Shaw EG, Scheithauer BW, O'Fallon JR, Tazelaar HD, Davis DH. Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg. 1992;76:428-434.
29. Simpson JR, Horton J, Scott C, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiât Oncol Biol Phys. 1993;26:239-244.
30. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neural Neurosurg Psychiatry. 1998;64:581-587.
31. Vecht CJ, Avezaat CJ, van Putten WL, Eijkenboom WM, Stefanko SZ. The influence of the extent of surgery on the neurological function and survival in malignant glioma: a retrospective analysis in 243 patients. J Neural Neurosurg Psychiatry. \990;53:466-471.
32. Berger MS, Kincaid J, Ojemann GA, Lettich E. Brain mapping techniques to maximize resection, safety, and seizure control in children with brain tumors. Neurosurgery. 1989;25:786-792.
33. Black PM, Ronner SF. Cortical mapping for defining the limits of tumor resection. Neurosurgery. 1987;20:914-919.
34. Walsh AR, Schmidt RH, Marsh HT. Cortical mapping and local anaesthetic resection as an aid to surgery of low and intermediate grade gliomas. BrJ Neurosurg. 1992;6:119-124.
35. Kelly PJ, Daumas-Duport C, Kispert DB, Kail BA, Scheithauer BW, Illig JJ. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg. 1987;66:865-874.
36. Ranck JB Jr. Which elements are excited in electrical stimulation of mammalian central nervous system: a review. Brain Res. 1975;98: 417-440.
37. Dean BL, Drayer BP, Bird CR, et al. Gliomas: classification with MR imaging. Radiology. 1990; 174:411-415.
38. Earnest F IV, Kelly PJ, Scheithauer BW, et al. Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology. 1988;166:823-827.
39. Stack JP, Antoun NM, Jenkins JP, Metcalfe R, Isherwood I. Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brain. Neuroradiology. 1988;30:145-154.
40. Tovi M, Lilja A, Bergstrom M, Ericsson A, Bergstrom K, Hartman M. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radial. 1990;31:417-429.
41. Butler AR, Horii SC, Kricheff II, Shannon MB, Budzilovich GN. Computed tomography in astrocytomas: a statistical analysis of the parameters of malignancy and the positive contrast-enhanced CT scan. Radiology. 1978; 129:433-439.
42. Dubois PJ. Brain tumors: supratentorial hemispheric tumors: glioma. In: Rosenberg RN, Heinz ER, eds. The Clinical Neurosciences: Neuroradiology. New York, NY: Churchill Livingstone; 1984:361-455.
43. Hammoud MA, Sawaya R, Shi W, Thall PF, Leeds NE. Prognostic significance of preoperative MRI scans in glioblastoma multiforme. JNeurooncol. 1996;27:65-73.
44. Chamberlain MC, Murovic JA, Levin VA. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas [published correction appears in Neurology. 1988;38:1816].Afero/0£y. 1988;38:1371-1374.
45. Kondziolka D, Lundsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma J Neurosurg. 1993;79:533-536.
46. Perez-Cruet MJ, Adelman L, Anderson M, Roth PA, Ritter AM, Saris SC. CT-guided stereotactic biopsy of nonenhancing brain lesions. Stereotact Funct Neurosurg. 1993;61:105-117.
47. Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neural. 1998;49:436-440.
48. Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP. Oligodendrogliomas, part I: patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol. 1997;34:37-59.
49. Edwards-Brown MK. Supratentorial brain tumors. Neuroimaging Clin N Am. 1994;4:437-455.
50. Masters LT, Zimmerman RD. Imaging of supratentorial brain tumors in adults. Neuroimaging Clin N Am. 1993;3:649-669.
51. Bricolo A, Turazzi S, Cristofori L, et al. Experience in "radical" surgery of supratentorial gliomas in adults. J Neurosurg Sei. 1990;34:297-298.
52. Curran WJ Jr, Scott CB, Horton J, et al. Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? a report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol. 1992;12:219-227.
53. Kreth FW, Warnke PC, Scheremet R, Ostertag CB. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg. 1993;78: 762-766.
54. Keles GE, Anderson B, Berger MS. The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neural. 1999;52:371-379.
55. Berger MS, Deliganis AV, Dobbins J, Keles GE. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer. 1994;74:1784-1791.
56. Miralbell R, Balart J, Matias-Guiu X, Molet J, Ariza A, CravenBartle J. Radiotherapy for supratentorial low-grade gliomas: results and prognostic factors with special focus on tumour volume parameters. Radiother Oncol. 1993;27:112-116.
57. Devaux B, Chassoux F, Landre E, et al. Chronic intractable epilepsy associated with a tumor located in the central region: functional mapping data and postoperative outcome. Stereotact Fund Neurosurg. 1997;69(l-4, pt 2):229-238.
58. Ganslandt O, Steinmeier R, Kober H, et al. Magnetic source imaging combined with image-guided frameless stereotaxy: a new method in surgery around the motor strip. Neurosurgery. 1997;41: 621-627.
59. Rambo WM Jr, Sawaya RE. Neurosurgery of brain tumors. Neuroimaging Clin N Am. 1993;3:745-753.
60. Stapleton SR, Kiriakopoulos E, Mikulis D, et al. Combined utility of functional MRI, cortical mapping, and frameless stereotaxy in the resection of lesions in eloquent areas of brain in children. Pediatr Neurosurg. 1997;26:68-82.
61. Lumenta CB, Gumprecht HK, Leonard! MA, Gerstner W, Brehm B. Three-dimensional computer-assisted stereotactic-guided microneurosurgery combined with cortical mapping of the motor area by direct electrostimulation. Minim Invasive Neurosurg. 1997; 40:50-54.
62. Berger MS. Functional mapping-guided resection of low-grade gliomas. Clin Neurosurg. 1995;42:437-452.
63. Hoshino T, Wilson CB. Cell kinetic analyses of human malignant brain tumors (gliomas). Cancer. 1979;44:956-962.
64. Laws ER Jr, Taylor WF, Clifton MB, Okazaki H. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg. 1984;61:665-673.
65. Muller W, Afra D, Schröder R. Supratentorial recurrences of gliomas: morphological studies in relation to time intervals with oligodendrogliomas. Acta Neurochir (Wien). 1977;39:15-25.
66. Soffietti R, Chio A, Giordana MT, Vasario E, Schiffer D. Prognostic factors in well-differentiated cerebral astrocytomas in the adult. Neurosurgery. 1989;24:686-692.
67. Wallner KE, Gonzales M, Sheline GE. Treatment of oligodendrogliomas with or without postoperative irradiation. J Neurosurg. 1988;68:684-688.
68. Muller W, Afra D, Schröder R. Supratentorial recurrences of gliomas: morphological studies in relation to time intervals with astrocytomas. Acta Neurochir (Wien). 1977;37:75-91.
69. Burger PC, Dubois PJ, Schold SC Jr, et al. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg. 1983;58:159169.
70. Kelly PJ, Daumas-Duport C, Scheithauer BW, Kail BA, Kispert DB. Stereotactic histologie correlations of computed tomographyand magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc. 1987;62:450-459.
71. Mosskin M, von Holst H, Bergstrom M, et al. Positron emission tomography with 11 C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies. Acta Radial. 1987;28:673-681.